HBM Holdings (HKSE:02142) Short Interest

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02142 HBM Holdings Ltd HKSE:02142
73 GF Score
Price HK$11.69
GF Value HK$7.03
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is HBM Holdings Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

HKSE:02142 vs VRTX, REGN, RVMD: Short Interest Comparison

For the Biotechnology subindustry, HBM Holdings's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

HBM Holdings Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, HBM Holdings's Short Interest distribution charts can be found below:

* The bar in red indicates where HBM Holdings's Short Interest falls into.


HKSE:02142
73GF Score
HBM Holdings Ltd HKSE:02142
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is HBM Holdings (HKSE:02142) Overvalued in 2026?

Based on GuruFocus' analysis, HBM Holdings stock appears to be overvalued. The current stock price of HK$11.69 is trading 66.3% above its estimated GF Value™ of HK$7.03. GuruFocus considers HBM Holdings to be Significantly Overvalued.

Key valuation signals for HKSE:02142:

  • Short Interest:
  • GF Value™: HK$7.03 vs. price of HK$11.69 (66.3% above fair value)
  • GF Score™: 73/100 with 4 warning signs

No single metric tells the full story. See the HKSE:02142 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

HBM Holdings Business Description

Other Exchanges 6XY:Germany
Address No. 388 Fenglin Road, 6th Floor, Tower B, Fenglin International Phase I, Xuhui District, Shanghai, CHN, 200032
HBM Holdings Ltd is a clinical-stage biopharmaceutical company engaged in the discovery and development of differentiated antibody therapeutics in immunology and oncology disease areas. Its products under development are Batoclimab, for the treatment of a wide spectrum of autoimmune diseases; Tanfanercept, for the treatment of moderate-to-severe dry eye disease (DED); HBM4003; HBM9378, to prevent and treat COVID-19, the pandemic respiratory disease caused by the SARS-CoV-2 virus; HBM7008; and others. Its geographical segments are Mainland China, United States, Europe, and others. The majority of the revenue for the firm is generated from the Europe.
73GF Score

Get the complete analysis for HKSE:02142

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$11.69
Price
HK$7.03
GF Value